Source: DGNews | Posted 8 years ago
FDA Approves Enbrel (Etanercept) As Treatment To Improve Physical Function In Rheumatoid Arthritis Patients
Tags:
THOUSAND OAKS, CA and COLLEGEVILLE, PA -- August 1, 2003 -- Amgen (Nasdaq: AMGN) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced that the U.S. Food and Drug Administration (FDA) approved an expanded indication for Enbrel
Comments